Biodesix, Inc.: H.C. Wainwright cuts target price to $34 from $38
BDSX•H.C. Wainwright cut its target price for Biodesix, Inc. to $34 from $38.
Related News
Air Industries Group swings to third-quarter net profit of $946,000; sales rise 41% to $14.55 million
AIRI•
Spruce Biosciences transfers CRHX-101 program to Adrenyx Biosciences
SPRB•
Ocular Therapeutix Q3 EPS USD -0.42
OCUL•
Jersey Mike's Subs enters Europe with first UK location
JMKE•
Powerfleet Q2 gross profit $61.826 million
AIOT•